Page 12 - Sohini Das

India should expedite efforts to become full ICH member: ISCR president

Policymakers should establish dedicated clinical research units within premier institutions like Aiims and NIPERs, regulatory authorities too would need support in developing their domain expertise

Pharma companies likely to pass on costs in US as fresh levy looms

Brokerages also felt that the pharma companies will aim to pass on the tariff hike to payors

Short-term painkiller? Pharma Inc gets a breather from US tariffs

Tariff worries, raw material costs still ail sector

Drug prices may rise in US if Indian pharma firms pass on Trump's tariff

The US administration has not made announcements yet on sector-specific tariffs

Fortis Healthcare secures rights to Fortis brand in public auction

Wins bid for Rs 200 crore at December auction to acquire trademark

'Scenario building' in Indian Pharma Inc ahead of US tariff announcement

Pharma products have been on the radar of US President Donald Trump, who has indicated that tariffs of up to 25 per cent could be imposed on this sector

Agilus Diagnostics lowers marketing spend 2 years after rebranding

In FY25, an additional Rs 50 crore was spent on marketing over and above the usual budget

Auto street set for rough ride as Donald Trump tariffs spark worries

India calculating impact of 25% duty on cars, auto parts; firms see hit on margins

Manufacturing sector must not rely on tariffs for cover: India Inc

With supply chain uncertainties looming, companies are trying to procure more components and create an inventory, felt industry insiders

M&M in talks to acquire Sumitomo Corporation's stake in SML Isuzu

Sumitomo holds 44% in SML Isuzu; current stake valued at Rs 1,100 cr; deal may happen at a discount to current trading price

Used-car sales likely to outpace new ones in FY26 as demand surges

Secondhand-car market seeing strong growth in Bengaluru, Hyderabad, Pune

Booster shot: Mounjaro may emerge as a sweet pill for Eli Lilly in India

Analysts say the diabetes and obesity drug can be a Rs 500 crore opportunity for the firm

Italian super-luxury carmaker Lamborghini's India drive: Catch them young

India ranks 6th in Asia-Pac for the Italian super luxury carmaker

Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India. Prices here

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what you need to know

Premium tyres market to treble in 3-5 years: CEAT MD & CEO Arnab Banerjee

Currently, commercial vehicle tyres and passenger vehicle tyres are split 50:50 in Ceat's sales. PCR sales account for around 20 per cent of passenger vehicle tyres

India sales may rev up soon to be among top 5 markets for Mercedes-Maybach

Mercedes-Benz India had its best year in its 30-year history in 2024, selling 19,565 vehicles-a 12.4 per cent year-on-year growth

Diarrhoea and viral infections spur sales of probiotics, shows data

Antidiarrheals and anti-flatulents have also grown in strong double digits - 36 per cent and 29 per cent, respectively

PV sales to end FY25 flat with 3.82 mn units sold in wholesale till Feb

Auto industry braces for sluggish growth in FY26 amid affordability concerns

Generics surge as patent expiry restores mkt pulse, boosting drug volumes

An analysis by Pharmarack, a market research firm, showed that 226 vildagliptin (anti-diabetic) brands are now available in the market after Novartis' patent expired in December 2019

Key diabetes drug price crashes by up to 90% as generics enter market

Mankind, Alkem, Glenmark launch generic versions of empagliflozin